A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A CLINICAL STUDY TO COMPARE EFFICACY AND SAFETY OF TWO DIFFERENT DOSES OF CAGRISEMA AND SEMAGLUTIDE IN PARTICIPANTS WITH OBESITY WITH OR WITHOUT TYPE 2 DIABETES

Intervention/treatment:
CAGRILINTIDE-SEMAGLUTIDE (CAGRISEMA)
Medical condition:
OBESITY
Protocol code:
NN9838-7910
Control number:
303609
Status:
Recruiting
Approved:
May 07, 2026
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT07564414
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Novo Nordisk
Role
CONTACT
Phone:
(+1) 866-867-7178
Sponsor
NOVO NORDISK CANADA INC

Locations

Alpha Recherche Clinique - Lebourgneuf
Québec, G2J 0C4
RECRUITING
Diex Recherche Quebec
Québec, G1V 4T3
RECRUITING

Alberta

C-Health Partners
Calgary, Alberta, T2V 4J2
RECRUITING

British Columbia

Dr. M.B. Jones Inc
Victoria, British Columbia, V8V 4A1
RECRUITING
Hilltop Medical Clinic
Surrey, British Columbia, V4A 0C1
RECRUITING
Kelowna Health and Memory Centre Ltd.
Kelowna, British Columbia, V1Y 5A8
RECRUITING
Medical Arts Health Research Group_Kelowna
Kelowna, British Columbia, V1Y4N7
RECRUITING
Ocean West Research Clinic
Surrey, British Columbia, V3Z 2N6
RECRUITING

New Brunswick

G.A. Research Associates Ltd.
Moncton, New Brunswick, E1G 1A7
RECRUITING

Nova Scotia

Care Access Cape Breton
Sydney, Nova Scotia, B1M 0A1
RECRUITING
Nova Scotia Hlth Halifax
Halifax, Nova Scotia, B3H1V7
RECRUITING

Ontario

Apex Trials
Guelph, Ontario, N1G 0B4
NOT_YET_RECRUITING
Bluewater Clin Res Group Inc
Sarnia, Ontario, N7T 4X3
RECRUITING
Centricity Research Brampton Endocrinology
Brampton, Ontario, L6S 0C6
RECRUITING
Diabetes Heart Research Centre
Toronto, Ontario, M6G 1M2
RECRUITING
Hamilton Medical Research Group
Hamilton, Ontario, L8L 5G4
RECRUITING
Milestone Research
London, Ontario, N5W 6A2
RECRUITING
Premier Clinical Trial Research Network (PCTRN)
Hamilton, Ontario, L8L 5G4
RECRUITING
Wharton Medical Clinic Clinical Trials (Hamilton)
Hamilton, Ontario, L8L 5G8
RECRUITING

Quebec

Centre Medical Acadie
Montreal, Quebec, H4N 2W2
RECRUITING
Centricity Res Pointe-Claire
Pointe-Claire, Quebec, H9R 4S3
RECRUITING
Did you find what you were looking for?